1. Home
  2. HUDI vs AIMD Comparison

HUDI vs AIMD Comparison

Compare HUDI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

HOLD

Current Price

$1.25

Market Cap

17.3M

Sector

Industrials

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$2.43

Market Cap

16.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
AIMD
Founded
1998
1984
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
16.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HUDI
AIMD
Price
$1.25
$2.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.8K
43.8K
Earning Date
08-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,566,370.00
$113,037.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
178.19
52 Week Low
$1.06
$1.78
52 Week High
$5.46
$5.00

Technical Indicators

Market Signals
Indicator
HUDI
AIMD
Relative Strength Index (RSI) 47.67 45.20
Support Level $1.23 $2.03
Resistance Level $1.34 $2.56
Average True Range (ATR) 0.07 0.18
MACD 0.01 0.08
Stochastic Oscillator 60.47 78.21

Price Performance

Historical Comparison
HUDI
AIMD

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: